197 related articles for article (PubMed ID: 28339182)
1. Widespread and Indiscriminate Nanosilver Use: Genuine Potential for Microbial Resistance.
Gunawan C; Marquis CP; Amal R; Sotiriou GA; Rice SA; Harry EJ
ACS Nano; 2017 Apr; 11(4):3438-3445. PubMed ID: 28339182
[TBL] [Abstract][Full Text] [Related]
2. Heritable nanosilver resistance in priority pathogen: a unique genetic adaptation and comparison with ionic silver and antibiotics.
Valentin E; Bottomley AL; Chilambi GS; Harry EJ; Amal R; Sotiriou GA; Rice SA; Gunawan C
Nanoscale; 2020 Jan; 12(4):2384-2392. PubMed ID: 31930233
[TBL] [Abstract][Full Text] [Related]
3. Development of Nanoparticle Adaptation Phenomena in Acinetobacter baumannii: Physiological Change and Defense Response.
McNeilly O; Mann R; Cummins ML; Djordjevic SP; Hamidian M; Gunawan C
Microbiol Spectr; 2023 Feb; 11(1):e0285722. PubMed ID: 36625664
[TBL] [Abstract][Full Text] [Related]
4. A Review on Potential Role of Silver Nanoparticles and Possible Mechanisms of their Actions on Bacteria.
Khalandi B; Asadi N; Milani M; Davaran S; Abadi AJ; Abasi E; Akbarzadeh A
Drug Res (Stuttg); 2017 Feb; 67(2):70-76. PubMed ID: 27824432
[TBL] [Abstract][Full Text] [Related]
5. Polysulfone ultrafiltration membranes impregnated with silver nanoparticles show improved biofouling resistance and virus removal.
Zodrow K; Brunet L; Mahendra S; Li D; Zhang A; Li Q; Alvarez PJ
Water Res; 2009 Feb; 43(3):715-23. PubMed ID: 19046755
[TBL] [Abstract][Full Text] [Related]
6. Evolution of biofilm-forming pathogenic bacteria in the presence of nanoparticles and antibiotic: adaptation phenomena and cross-resistance.
Mann R; Holmes A; McNeilly O; Cavaliere R; Sotiriou GA; Rice SA; Gunawan C
J Nanobiotechnology; 2021 Sep; 19(1):291. PubMed ID: 34579731
[TBL] [Abstract][Full Text] [Related]
7. Induced adaptation of Bacillus sp. to antimicrobial nanosilver.
Gunawan C; Teoh WY; Marquis CP; Amal R
Small; 2013 Nov; 9(21):3554-60. PubMed ID: 23625828
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-hyaluronic acid/nano silver composite sponges for drug resistant bacteria infected diabetic wounds.
Anisha BS; Biswas R; Chennazhi KP; Jayakumar R
Int J Biol Macromol; 2013 Nov; 62():310-20. PubMed ID: 24060281
[TBL] [Abstract][Full Text] [Related]
9. Bacterial resistance to silver nanoparticles and how to overcome it.
Panáček A; Kvítek L; Smékalová M; Večeřová R; Kolář M; Röderová M; Dyčka F; Šebela M; Prucek R; Tomanec O; Zbořil R
Nat Nanotechnol; 2018 Jan; 13(1):65-71. PubMed ID: 29203912
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles against resistant Pseudomonas spp.
Venegas MA; Bollaert MD; Jafari A; Bondoc JMG; Twilley J; Thompson W; Movahedzadeh F
Microb Pathog; 2018 May; 118():115-117. PubMed ID: 29548697
[TBL] [Abstract][Full Text] [Related]
11. Nanoantibiotics: strategic assets in the fight against drug-resistant superbugs.
Khurana C; Chudasama B
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):3-6. PubMed ID: 29593387
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of antibacterial efficacy of phyto fabricated silver nanoparticles using Mukia scabrella (Musumusukkai) against drug resistance nosocomial gram negative bacterial pathogens.
Prabakar K; Sivalingam P; Mohamed Rabeek SI; Muthuselvam M; Devarajan N; Arjunan A; Karthick R; Suresh MM; Wembonyama JP
Colloids Surf B Biointerfaces; 2013 Apr; 104():282-8. PubMed ID: 23334182
[TBL] [Abstract][Full Text] [Related]
13. Effects of Silver Nanoparticles on Multiple Drug-Resistant Strains of Staphylococcus aureus and Pseudomonas aeruginosa from Mastitis-Infected Goats: An Alternative Approach for Antimicrobial Therapy.
Yuan YG; Peng QL; Gurunathan S
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272303
[TBL] [Abstract][Full Text] [Related]
14. Nanosilver and the microbiological activity of the particulate solids versus the leached soluble silver.
Faiz MB; Amal R; Marquis CP; Harry EJ; Sotiriou GA; Rice SA; Gunawan C
Nanotoxicology; 2018 Apr; 12(3):263-273. PubMed ID: 29447029
[TBL] [Abstract][Full Text] [Related]
15. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance.
Wang H; Wang M; Xu X; Gao P; Xu Z; Zhang Q; Li H; Yan A; Kao RY; Sun H
Nat Commun; 2021 Jun; 12(1):3331. PubMed ID: 34099682
[TBL] [Abstract][Full Text] [Related]
16. Negatively charged silver nanoparticles with potent antibacterial activity and reduced toxicity for pharmaceutical preparations.
Salvioni L; Galbiati E; Collico V; Alessio G; Avvakumova S; Corsi F; Tortora P; Prosperi D; Colombo M
Int J Nanomedicine; 2017; 12():2517-2530. PubMed ID: 28408822
[TBL] [Abstract][Full Text] [Related]
17. The kinetics of thermal instability in nanocrystalline silver and the effect of heat treatment on the antibacterial activity of nanocrystalline silver dressings.
Landry BK; Nadworny PL; Omotoso OE; Maham Y; Burrell JC; Burrell RE
Biomaterials; 2009 Dec; 30(36):6929-39. PubMed ID: 19766307
[TBL] [Abstract][Full Text] [Related]
18. Tailoring shape and size of biogenic silver nanoparticles to enhance antimicrobial efficacy against MDR bacteria.
Kumari M; Pandey S; Giri VP; Bhattacharya A; Shukla R; Mishra A; Nautiyal CS
Microb Pathog; 2017 Apr; 105():346-355. PubMed ID: 27889528
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial properties of biosynthesized silver nanoparticles studied by flow cytometry and related techniques.
Railean-Plugaru V; Pomastowski P; Rafinska K; Wypij M; Kupczyk W; Dahm H; Jackowski M; Buszewski B
Electrophoresis; 2016 Mar; 37(5-6):752-61. PubMed ID: 26763104
[TBL] [Abstract][Full Text] [Related]
20. Enhanced antibacterial efficacy of silver nanoparticles immobilized in a chitosan nanocarrier.
Sharma S
Int J Biol Macromol; 2017 Nov; 104(Pt B):1740-1745. PubMed ID: 28736042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
